FDA Inspection 1226820 — Nina Magnolo, MD, Clinical Investigator
The FDA completed an inspection of Nina Magnolo, MD, Clinical Investigator on Dec 1, 2023 in Munster. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 1, 2023
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Munster (Germany)
Additional Details
Clinical Investigator (CI)